Vasoactive intestinal polypeptide
VIP
systemic
coronary vasodilator
positive
inotropic
Myocardial levels
VIP
assayed
development
heart failure
canine
models
cobalt cardiomyopathy
induced
dogs
VIP
radioimmunoassay
decreased
SD
dogs
doxorubicin-induced heart failure
VIP
decreased
VIP
content
left ventricular muscle
resected
hearts
patients
heart transplant
papillary muscles
patients
rheumatic disease
myxomatous degeneration
mitral valve prostheses
myocardial
VIP
concentration
hearts
patients
coronary disease
patient
transplant
mitral prostheses
patients
transplantation
ejection fraction
VIP
level
hearts
coronary artery disease
average ejection fraction
group
VIP
concentration
hearts
patients
coronary disease
hearts
patients
transplant
Myocardial catecholamines
subjects
weak
correlation
tissue
concentrations
VIP
norepinephrine
noted.(ABSTRACT TRUNCATED AT 250 WORDS
